Answer
The monotherapy licence is restricted to cancers with an activating ESR1 mutation, so a validated tumour or plasma test is required.
Sources for this answer
- Inluriyo 200 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.